866-997-4948 (US-Canada Toll Free)

Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Published By :

Transparency

Published Date : 2013-08-30

Category :

In Vitro Diagnostics

No. of Pages : 84

Product Synopsis

This report studies the global market for companion diagnostics from two perspectives – companion diagnostics by indication and by geography. The market for companion diagnostics by indication includes sub-segments such as breast cancer, lung cancer, colorectal cancer, gastric cancer, melanoma and others (HIV, Thalassemia). By geography, the companion diagnostics market has been divided into four regions, namely, North America, Europe, Asia-Pacific and RoW. Market size and forecast for each segment and sub-segment has been provided for the period 2011 to 2019 in terms of USD million, with 2012 as the base year. The compounded annual growth rate (CAGR) for each market segment has been provided for the forecast period (2013 to 2019). The report also contains a section on... Read More

Table Of Content

Table of Contents

Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation
1.4 List Of Abbreviations

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Introduction
3.2 Market Drivers
3.2.1 Rising Need For Companion Diagnostics Along With Targeted Therapies
3.2.2 Increasing Demand As Well As Developmental Efforts Towards Personalized Medicine
3.2.3 The Pharmacoeconomic Advantage: Reduced Drug Development Costs
3.2.4 Increasing Cancer Incidence Worldwide
3.2.5 Impact Analysis Of Market Drivers
3.3 Market Restraints
3.3.1 Effect Of Influence Of Advocacy Groups And Clinical Societies
3.3.2 Prolonged Developmental And Approval Phases
3.3.3 Impact Analysis Of Market Restraints
3.4 Market Opportunities
3.4.1 Expansion Into Newer Indication Areas
3.5 Porter’s Five Force Analysis: Global Companion Diagnostics Market
3.5.1 Bargaining Power Of Buyers
3.5.2 Bargaining Power Of Suppliers
3.5.3 Threat Of Substitutes
3.5.4 Threat Of New Entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Companion Diagnostics Market, By Geography, 2012

Chapter 4 Companion Diagnostics Market, By Indications, 2011 - 2019 (USD Million)
4.1 Introduction
4.1.1 Comparative Analysis: Global Companion Diagnostics Market, By Indication, 2012 & 2019 (Value %)
4.1.2 Breast Cancer
4.1.3 Lung Cancer
4.1.4 Colorectal Cancer
4.1.5 Gastric Cancer
4.1.6 Melanoma
4.1.7 Others (HIV, Thalassemia)

Chapter 5 Companion Diagnostics Market, By Geography, 2011 - 2019 (USD Million)
5.1 Overview
5.1.1 Comparative Analysis: Global Companion Diagnostics Market, By Geography, 2012 & 2019 (Value %)
5.2 North America
5.2.1 North America Companion Diagnostics Market Size And Forecast, 2011 - 2019 (USD Million)
5.3 Europe
5.3.1 Europe Companion Diagnostics Market Size And Forecast, 2011 - 2019 (Usd Million)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Companion Diagnostics Market Size And Forecast, 2011 - 2019 (USD Million)
5.5 Rest Of The World (Row)
5.5.1 Row Companion Diagnostics Market Size And Forecast, 2011 - 2019 (USD Million)

Chapter 6 Competitive Landscape
6.1 Market Share By Key Players, 2012 (%)

Chapter 7 Recommendations
7.1 Changing Business Models of Pharmaceutical and Diagnostics Manufacturers
7.2 Investing in Emerging Economies

Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.5 Recent Developments
8.2 Agendia N.V.
8.2.1 Company Overview
8.2.2 Product Portfolio
8.2.3 Business Strategies
8.2.4 Recent Developments
8.3 Agilent Technologies, Inc.,
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.5 Recent Developments
8.4 Biogenex Laboratories, Inc.
8.4.1 Company Overview
8.4.2 Product Portfolio
8.4.3 Business Strategies
8.4.4 Recent Developments
8.5 Ge Healthcare Ltd.
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.5.5 Recent Developments
8.6 Genomic Health, Inc.
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Developments
8.7 Laboratory Corporation Of America Holdings (Labcorp)
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.5 Recent Developments
8.8 Life Technologies Corporation
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Product Portfolio
8.8.4 Business Strategies
8.8.5 Recent Developments
8.9 Qiagen N.V.
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.5 Recent Developments
8.10 Resonance Health Analysis Services Pty Ltd.
8.10.1 Company Overview
8.10.2 Product Portfolio
8.10.3 Business Strategies
8.10.4 Recent Developments
8.11 Roche Holdings Ag
8.11.1 Company Overview
8.11.2 Financial Overview
8.11.3 Product Portfolio
8.11.4 Business Strategies
8.11.5 Recent Developments
8.12 Siemens Healthcare
8.12.1 Company Overview
8.12.2 Financial Overview
8.12.3 Product Portfolio
8.12.4 Business Strategies
8.12.5 Recent Developments

List of Tables


TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Companion Diagnostics Market
TABLE 3 Impact Analysis of Market Drivers
TABLE 4 Impact Analysis of Market Restraints
TABLE 5 Global Companion Diagnostics Market, by Indications, Size and Forecast, 2011 - 2019 (USD Million)
TABLE 6 Global Companion Diagnostics Market, by Geography, Size and Forecast, 2011 - 2019 (USD Million)

List of Figures


FIG. 1 Companion Diagnostics Market Segmentation
FIG. 2 Global Companion Diagnostics Market, by Indication, 2012 (USD Million)
FIG. 3 Porter’s Five Force Analysis: Global Companion Diagnostics Market
FIG. 4 Market Attractiveness Analysis: Global Companion Diagnostics Market, by Geography, 2012
FIG. 5 Comparative Analysis: Global Companion Diagnostics Market, by Indications, 2012 & 2019 (Value %)
FIG. 6 Global Breast Cancer Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 7 Global Lung Cancer Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 8 Global Colorectal Cancer Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 9 Global Gastric Cancer Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 10 Global Melanoma Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 11 Global Other Companion Diagnostics Market, Size and Forecast, 2011-2019 (USD Million)
FIG. 12 Comparative Analysis: Global Companion Diagnostics Market, by Geography, 2012 & 2019 (Value %)
FIG. 13 North American Market for Companion Diagnostics, Size and Forecast, 2011–2019 (USD Million)
FIG. 14 European Market for Companion Diagnostics, Size and Forecast, 2011– 2019 (USD Million)
FIG. 15 Asia-Pacific Market for Companion Diagnostics, Size and Forecast, 2011–2019 (USD Million)
FIG. 16 RoW Market for Companion Diagnostics, Size and Forecast, 2011–2019 (USD Million)
FIG. 17 Market Share Analysis: Companion Diagnostics Market, 2012 (%)
FIG. 18 Annual Revenues: Abbott Laboratories,  2010–2012 (USD Million)
FIG. 19 Annual Revenues: Agilent Technologies, Inc., 2010–2012 (USD Million)
FIG. 20 Annual Revenues: GE Healthcare, 2010–2012 (USD Million)
FIG. 21 Annual Revenues: Genomic Health, Inc.,  2010–2012 (USD Million)
FIG. 22 Annual Revenues: LabCorp,  2010–2012 (USD Million)
FIG. 23 Annual Revenues: Life Technologies Corporation, 2010–2012 (USD Million)
FIG. 24 Annual Sales: Qiagen N.V., 2010–2012 (USD Million)
FIG. 25 Annual Revenues: Roche Holdings AG, 2010–2012 (USD Million) (1Swiss Franc = 1.09 USD) (USD Million)
FIG. 26 Annual Revenues: Siemens Healthcare, 2010–2012 (USD Million)

Make an enquiry before buying this Report

Please fill the enquiry form below.

Full Name * Message
Your Email *
Job Title
Phone No. * (Pls. Affix Country Code) Security Code *

Upcoming Reports

  • Still Drinks Market - Global Industry Analysis, Market Size, Share, Growth, Trends And Forecast, 2012 - 2018

    By - Transparency

    Description Still drinks refers to drinks that include ready-to-drink fruit or non-fruit that typically contains juice content of lower than 25 percent, and water is also included in this sweetened flavor. Generally, in most countries consumers don’t tend to distinguish between juices, nectars, and the still drinks. It’s mostly the price that determines the consumer buying rather than the juice content. Of all the categories under the soft drinks, the still drinks market has shown continual growth with volumes advancing by almost close to 7% which is highest after...

  • Starch Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

    By - Transparency

    Starch is a tasteless and odorless white powder made up of linear and helical molecules. All green plants store their energy in the form of carbohydrate with large glucose units. This stored energy in carbohydrate form is known as starch. The glucose units present in starch are joined together by glycosidic bonds. Starch is the most commonly used constituent of the human food diet. Starch processing industries produce many types of sugars. Other processing industries of starch include glue making, pastes and adhesives. Starch production is fairly high in developed countries whereas...

  • Phosphates Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

    By - Transparency

    Phosphate is a naturally occurring element in the form of phosphorous found in many phosphate minerals. Most of the phosphate is used in fertilizer production hence increasing the demand for phosphate production. It is also used in animal feed, food industry and other industrial usage. The global phosphate market is expected to show spurring growth from developing countries of Asia-Pacific, Middle East and Latin America. The growth in these regions is primarily driven by increasing use of fertilizers in agriculture and rising demand for detergents, hence transforming these regions...